Literature DB >> 26425385

Possible Benefit of Dietary Carnosine towards Depressive Disorders.

Alan R Hipkiss1.   

Abstract

Many stress-related and depressive disorders have been shown to be associated with one or more of the following; shortened telomeres, raised cortisol levels and increased susceptibility to age-related dysfunction. It is suggested here that insufficient availability of the neurological peptide, carnosine, may provide a biochemical link between stress- and depression-associated phenomena: there is evidence that carnosine can enhance cortisol metabolism, suppress telomere shortening and exert anti-aging activity in model systems. Dietary supplementation with carnosine has been shown to suppress stress in animals, and improve behaviour, cognition and well-being in human subjects. It is therefore proposed that the therapeutic potential of carnosine dietary supplementation towards stress-related and depressive disorders should be examined.

Entities:  

Keywords:  aging; carnosine; cognition; cortisol; depression; diet; human; stress; supplementation; telomeres

Year:  2015        PMID: 26425385      PMCID: PMC4567213          DOI: 10.14336/AD.2014.1211

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  47 in total

1.  Prevention of peroxynitrite-dependent damage by carnosine and related sulphonamido pseudodipeptides.

Authors:  M Fontana; F Pinnen; G Lucente; L Pecci
Journal:  Cell Mol Life Sci       Date:  2002-03       Impact factor: 9.261

2.  Natural dipeptides as mini-chaperones: molecular mechanism of inhibition of lens βL-crystallin aggregation.

Authors:  Antonina K Dizhevskaya; Konstantin O Muranov; Alexander A Boldyrev; Mikhail A Ostrovsky
Journal:  Curr Aging Sci       Date:  2012-12

3.  Carnosine inhibits (E)-4-hydroxy-2-nonenal-induced protein cross-linking: structural characterization of carnosine-HNE adducts.

Authors:  Yahua Liu; Guozhang Xu; Lawrence M Sayre
Journal:  Chem Res Toxicol       Date:  2003-12       Impact factor: 3.739

4.  Retardation of the senescence of cultured human diploid fibroblasts by carnosine.

Authors:  G A McFarland; R Holliday
Journal:  Exp Cell Res       Date:  1994-06       Impact factor: 3.905

5.  Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage.

Authors:  Seung-Hoon Baek; Ah Reum Noh; Kyeong-A Kim; Muhammad Akram; Young-Jun Shin; Eun-Sun Kim; Seong Woon Yu; Arshad Majid; Ok-Nam Bae
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

6.  Anserine and carnosine supplementation in the elderly: Effects on cognitive functioning and physical capacity.

Authors:  D Szcześniak; S Budzeń; W Kopeć; J Rymaszewska
Journal:  Arch Gerontol Geriatr       Date:  2014-05-02       Impact factor: 3.250

Review 7.  Physiology and pathophysiology of carnosine.

Authors:  Alexander A Boldyrev; Giancarlo Aldini; Wim Derave
Journal:  Physiol Rev       Date:  2013-10       Impact factor: 37.312

8.  Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder.

Authors:  I Shalev; T E Moffitt; A W Braithwaite; A Danese; N I Fleming; S Goldman-Mellor; H L Harrington; R M Houts; S Israel; R Poulton; S P Robertson; K Sugden; B Williams; A Caspi
Journal:  Mol Psychiatry       Date:  2014-01-14       Impact factor: 15.992

9.  Anti-stress effects of carnosine on restraint-evoked immunocompromise in mice through spleen lymphocyte number maintenance.

Authors:  Yi-Fang Li; Rong-Rong He; Bun Tsoi; Xiao-Di Li; Wei-Xi Li; Keiichi Abe; Hiroshi Kurihara
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

Review 10.  Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis.

Authors:  M W Miller; N Sadeh
Journal:  Mol Psychiatry       Date:  2014-09-23       Impact factor: 15.992

View more
  6 in total

Review 1.  Glycotoxins: Dietary and Metabolic Origins; Possible Amelioration of Neurotoxicity by Carnosine, with Special Reference to Parkinson's Disease.

Authors:  Alan R Hipkiss
Journal:  Neurotox Res       Date:  2018-02-07       Impact factor: 3.911

2.  On the use of carnosine and antioxidants: A letter from Russia.

Authors:  Sergei V Jargin
Journal:  J Intercult Ethnopharmacol       Date:  2016-04-21

Review 3.  Use of Carnosine for Oxidative Stress Reduction in Different Pathologies.

Authors:  V D Prokopieva; E G Yarygina; N A Bokhan; S A Ivanova
Journal:  Oxid Med Cell Longev       Date:  2016-01-24       Impact factor: 6.543

4.  Depression, Diabetes and Dementia: Formaldehyde May Be a Common Causal Agent; Could Carnosine, a Pluripotent Peptide, Be Protective?

Authors:  Alan R Hipkiss
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

Review 5.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

6.  Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.

Authors:  Kensaku Sakae; Machi Suka; Hiroyuki Yanagisawa
Journal:  J Clin Psychopharmacol       Date:  2020 Nov/Dec       Impact factor: 3.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.